메뉴 건너뛰기




Volumn 2, Issue 1, 2013, Pages 53-60

Serum extracellular vesicle protein levels are associated with acute coronary syndrome

Author keywords

ACS; acute coronary syndrome; biomarker; extracellular vesicle; protein

Indexed keywords


EID: 84990342833     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612471212     Document Type: Article
Times cited : (79)

References (49)
  • 1
    • 77951927068 scopus 로고    scopus 로고
    • Fact sheet no. 317. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html Published September 2011, consulted May
    • World Health Organization. Cardiovascular diseases (CVDs). Fact sheet no. 317. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html (Published September 2011, consulted May 2012).
    • (2012) Cardiovascular diseases (CVDs)
  • 2
    • 84856158305 scopus 로고    scopus 로고
    • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    • Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
    • (2011) Eur Heart J , vol.32 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2    Agewall, S.3
  • 3
    • 34547661900 scopus 로고    scopus 로고
    • ACC/AHA 2007 Guidelines for the management of patients with un-stable angina/non-ST-elevation myocardial infarction – executive summary
    • Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with un-stable angina/non-ST-elevation myocardial infarction – executive summary. J Am Coll Cardiol 2007; 50: 652-726.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 652-726
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3
  • 4
    • 78149290672 scopus 로고    scopus 로고
    • Acute Coronary Syndrome Chapter Collaborators
    • acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations
    • O'Connor RE, Bossaert L, Arntz HR, et al. Acute Coronary Syndrome Chapter Collaborators. Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010; 122: S422-S465.
    • (2010) Circulation , vol.122 , pp. S422-S465
    • O'Connor, R.E.1    Bossaert, L.2    Arntz, H.R.3
  • 5
    • 69349099937 scopus 로고    scopus 로고
    • Early diagnosis of myocardial infarction with sensitive cardiac troponin assays
    • Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-867.
    • (2009) N Engl J Med , vol.361 , pp. 858-867
    • Reichlin, T.1    Hochholzer, W.2    Bassetti, S.3
  • 6
    • 22844445444 scopus 로고    scopus 로고
    • New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations
    • Sanchis J, Bodí V, Núñez J, et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations. J Am Coll Cardiol 2005; 46: 443-449.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 443-449
    • Sanchis, J.1    Bodí, V.2    Núñez, J.3
  • 7
    • 58549114541 scopus 로고    scopus 로고
    • Highlights of a new type of intercellular communication: microvesicle-based information transfer
    • Pap E, Pállinger É, Pásztói M, et al. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009; 58: 1-8.
    • (2009) Inflamm Res , vol.58 , pp. 1-8
    • Pap, E.1    Pállinger, É2    Pásztói, M.3
  • 8
    • 67949097489 scopus 로고    scopus 로고
    • Exosomes-vesicular carriers for intercellular communication
    • Simons M and Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575-581.
    • (2009) Curr Opin Cell Biol , vol.21 , pp. 575-581
    • Simons, M.1    Raposo, G.2
  • 9
    • 77958098024 scopus 로고    scopus 로고
    • Exosomes/microvesicles as a mechanism of cell-to-cell communication
    • Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78: 838-848.
    • (2010) Kidney Int , vol.78 , pp. 838-848
    • Camussi, G.1    Deregibus, M.C.2    Bruno, S.3
  • 10
    • 78349285166 scopus 로고    scopus 로고
    • Microparticles: protagonists of a novel communication network for intercellular information exchange
    • Mause SF and Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-1057.
    • (2010) Circ Res , vol.107 , pp. 1047-1057
    • Mause, S.F.1    Weber, C.2
  • 11
    • 67349171666 scopus 로고    scopus 로고
    • Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation
    • Morel O, Pereira B, Averous G, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009; 204: 636-641.
    • (2009) Atherosclerosis , vol.204 , pp. 636-641
    • Morel, O.1    Pereira, B.2    Averous, G.3
  • 12
    • 79957493898 scopus 로고    scopus 로고
    • Microparticles in hemostasis and thrombosis
    • Owens AP and Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-1297.
    • (2011) Circ Res , vol.108 , pp. 1284-1297
    • Owens, A.P.1    Mackman, N.2
  • 13
    • 78149244101 scopus 로고    scopus 로고
    • Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
    • Shantsila E, Kamphuisen PW and Lip GYH. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8: 2358-2368.
    • (2010) J Thromb Haemost , vol.8 , pp. 2358-2368
    • Shantsila, E.1    Kamphuisen, P.W.2    Lip, G.Y.H.3
  • 15
    • 85027928556 scopus 로고    scopus 로고
    • Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis
    • Morel O, Morel N, Jesel L, et al. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011; 33: 469-486.
    • (2011) Semin Immunopathol , vol.33 , pp. 469-486
    • Morel, O.1    Morel, N.2    Jesel, L.3
  • 16
    • 78650891551 scopus 로고    scopus 로고
    • Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    • Tushuizen ME, Diamant M, Sturk A, et al. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscl Thromb Vasc Biol 2010; 31: 4-9.
    • (2010) Arterioscl Thromb Vasc Biol , vol.31 , pp. 4-9
    • Tushuizen, M.E.1    Diamant, M.2    Sturk, A.3
  • 17
    • 48249091633 scopus 로고    scopus 로고
    • Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles
    • Peterson DB, Sander T, Kaul S, et al. Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 2008; 8: 2430-2446.
    • (2008) Proteomics , vol.8 , pp. 2430-2446
    • Peterson, D.B.1    Sander, T.2    Kaul, S.3
  • 18
    • 2342551026 scopus 로고    scopus 로고
    • Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin
    • Simak J, Holada K and Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol 2002; 3: 11-20.
    • (2002) BMC Cell Biol , vol.3 , pp. 11-20
    • Simak, J.1    Holada, K.2    Vostal, J.G.3
  • 19
    • 65349177207 scopus 로고    scopus 로고
    • Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro
    • Antoniak S, Boltzen U, Eisenreich A, et al. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 2009; 7: 871-878.
    • (2009) J Thromb Haemost , vol.7 , pp. 871-878
    • Antoniak, S.1    Boltzen, U.2    Eisenreich, A.3
  • 21
    • 34047111681 scopus 로고    scopus 로고
    • Circulating microparticles: pathophysiology and clinical implications
    • Piccin A, Murphy WG and Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
    • (2007) Blood Rev , vol.21 , pp. 157-171
    • Piccin, A.1    Murphy, W.G.2    Smith, O.P.3
  • 22
    • 0032694867 scopus 로고    scopus 로고
    • In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
    • Combes V, Simon A-C, Grau G-E, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
    • (1999) J Clin Invest , vol.104 , pp. 93-102
    • Combes, V.1    Simon, A.-C.2    Grau, G.-E.3
  • 23
    • 0014082202 scopus 로고
    • The nature and significance of platelet products in human plasma
    • Wolf P. The nature and significance of platelet products in human plasma. Brit J Haematol 1967; 13: 269-288.
    • (1967) Brit J Haematol , vol.13 , pp. 269-288
    • Wolf, P.1
  • 24
    • 0032532360 scopus 로고    scopus 로고
    • Endothelial cell activation by leukocyte microparticles
    • Mesri M and Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161: 4382-4387.
    • (1998) J Immunol , vol.161 , pp. 4382-4387
    • Mesri, M.1    Altieri, D.C.2
  • 25
    • 84868319623 scopus 로고    scopus 로고
    • Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs
    • Oerlemans MI, Mosterd A, Dekker MS, et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 2012; 4: 1176-1185.
    • (2012) EMBO Mol Med , vol.4 , pp. 1176-1185
    • Oerlemans, M.I.1    Mosterd, A.2    Dekker, M.S.3
  • 26
    • 33747195313 scopus 로고    scopus 로고
    • IgA receptors in health and disease
    • Wines BD and Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006; 68: 103-114.
    • (2006) Tissue Antigens , vol.68 , pp. 103-114
    • Wines, B.D.1    Hogarth, P.M.2
  • 27
    • 84856657257 scopus 로고    scopus 로고
    • Sputum proteomics identifies elevated PIGR levels in smokers and mild- to-moderate COPD
    • Ohlmeier S, Mazur W, Linja-aho A, et al. Sputum proteomics identifies elevated PIGR levels in smokers and mild- to-moderate COPD. J Proteome Res 2012; 11: 599-608.
    • (2012) J Proteome Res , vol.11 , pp. 599-608
    • Ohlmeier, S.1    Mazur, W.2    Linja-aho, A.3
  • 28
    • 80155211998 scopus 로고    scopus 로고
    • Polymeric immunoglobulin receptor
    • Asano M and Komiyama K. Polymeric immunoglobulin receptor. J Oral Sci 2011; 52: 147–156.
    • (2011) J Oral Sci , vol.52 , pp. 147-156
    • Asano, M.1    Komiyama, K.2
  • 29
    • 0036329067 scopus 로고    scopus 로고
    • Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
    • Dharnidharka VR, Kwon C and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221–226.
    • (2002) Am J Kidney Dis , vol.40 , pp. 221-226
    • Dharnidharka, V.R.1    Kwon, C.2    Stevens, G.3
  • 30
    • 77954962468 scopus 로고    scopus 로고
    • Clinical utility of serum cystatin C in predicting coronary artery disease
    • Koc M, Batur MK and Karaarslan O. Clinical utility of serum cystatin C in predicting coronary artery disease. Cardiol J 2010; 17: 374–380.
    • (2010) Cardiol J , vol.17 , pp. 374-380
    • Koc, M.1    Batur, M.K.2    Karaarslan, O.3
  • 31
    • 78349234263 scopus 로고    scopus 로고
    • Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease
    • Kiyosue A, Hirata Y, Ando J, et al. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease. Circ J 2010; 74: 2441–2447.
    • (2010) Circ J , vol.74 , pp. 2441-2447
    • Kiyosue, A.1    Hirata, Y.2    Ando, J.3
  • 32
    • 66549090699 scopus 로고    scopus 로고
    • Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T
    • for the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators
    • Windhausen F, Hirsch A, Fischer J, et al.; for the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T. Clin Chem 2009; 55: 1118–1125.
    • (2009) Clin Chem , vol.55 , pp. 1118-1125
    • Windhausen, F.1    Hirsch, A.2    Fischer, J.3
  • 33
    • 84860210769 scopus 로고    scopus 로고
    • Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome
    • Ristiniemi N, Lund J, Tertti R, et al. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome. Clin Biochem 2012: 1–6.
    • (2012) Clin Biochem , pp. 1-6
    • Ristiniemi, N.1    Lund, J.2    Tertti, R.3
  • 34
    • 84860434853 scopus 로고    scopus 로고
    • Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction
    • Silva D, Cortez-Dias N, Jorge C, et al. Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction. Am J Cardiol 2012; 109: 1431–1438.
    • (2012) Am J Cardiol , vol.109 , pp. 1431-1438
    • Silva, D.1    Cortez-Dias, N.2    Jorge, C.3
  • 35
    • 6444224408 scopus 로고    scopus 로고
    • Cystatin C: a novel predictor of outcome in suspected or confirmed non- ST-elevation acute coronary syndrome
    • Jernberg T, Lindahl B, James S, et al. Cystatin C: a novel predictor of outcome in suspected or confirmed non- ST-elevation acute coronary syndrome. Circulation 2004; 110: 2342–2348.
    • (2004) Circulation , vol.110 , pp. 2342-2348
    • Jernberg, T.1    Lindahl, B.2    James, S.3
  • 36
    • 84864400404 scopus 로고    scopus 로고
    • Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population
    • The Tromso Study
    • Toft I, Solbu M, Kronborg J, et al. Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromso Study. Nephrol Dial Transplant 2012; 27: 2780–2787.
    • (2012) Nephrol Dial Transplant , vol.27 , pp. 2780-2787
    • Toft, I.1    Solbu, M.2    Kronborg, J.3
  • 37
    • 18644370841 scopus 로고    scopus 로고
    • Cystatin C and the risk of death and cardiovascular events among elderly persons
    • Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049–2060.
    • (2005) N Engl J Med , vol.352 , pp. 2049-2060
    • Shlipak, M.G.1    Sarnak, M.J.2    Katz, R.3
  • 38
    • 0032499629 scopus 로고    scopus 로고
    • Myocardial infarction and apoptosis after myocardial ischemia and reperfusion
    • Vakeva AP, Agah A, Rollins SA, et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Circulation 1998; 97: 2259–2267.
    • (1998) Circulation , vol.97 , pp. 2259-2267
    • Vakeva, A.P.1    Agah, A.2    Rollins, S.A.3
  • 40
    • 84860112830 scopus 로고    scopus 로고
    • The innate immune response in reperfused myocardium
    • Timmers L, Pasterkamp G, De Hoog VC, et al. The innate immune response in reperfused myocardium. Cardiovasc Res 2012; 94: 276–283.
    • (2012) Cardiovasc Res , vol.94 , pp. 276-283
    • Timmers, L.1    Pasterkamp, G.2    De Hoog, V.C.3
  • 41
    • 32044452429 scopus 로고    scopus 로고
    • Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease
    • Kostner KM, Fahti RB, Case C, et al. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clin Chim Acta 2006; 365: 129–134.
    • (2006) , vol.365 , pp. 129-134
    • Kostner, K.M.1    Fahti, R.B.2    Case, C.3
  • 42
    • 27544498810 scopus 로고    scopus 로고
    • Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis
    • Speidl WS, Exner M, Amighi J, et al. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 2005; 26: 2294–2299.
    • (2005) Eur Heart J , vol.26 , pp. 2294-2299
    • Speidl, W.S.1    Exner, M.2    Amighi, J.3
  • 44
    • 31644443751 scopus 로고    scopus 로고
    • Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
    • gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies
    • Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006; 47: S4–S20.
    • (2006) J Am Coll Cardiol , vol.47 , pp. S4-S20
    • Shaw, L.J.1    Merz, C.N.2    Pepine, C.J.3
  • 45
    • 31644449009 scopus 로고    scopus 로고
    • Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
    • gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease
    • Merz CNB, Shaw LJ, Reis SE, et al. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47: S21–S29.
    • (2006) J Am Coll Cardiol , vol.47 , pp. S21-S29
    • Merz, C.N.B.1    Shaw, L.J.2    Reis, S.E.3
  • 46
    • 70349211713 scopus 로고    scopus 로고
    • Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative
    • Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009; 158: 688–694.
    • (2009) Am Heart J , vol.158 , pp. 688-694
    • Gehrie, E.R.1    Reynolds, H.R.2    Chen, A.Y.3
  • 47
    • 0142122248 scopus 로고    scopus 로고
    • Microparticles in cardiovascular diseases
    • Van Wijk MJ, VanBavel E, Sturk A, et al. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277–287.
    • (2003) Cardiovasc Res , vol.59 , pp. 277-287
    • Van Wijk, M.J.1    VanBavel, E.2    Sturk, A.3
  • 48
    • 0038620493 scopus 로고    scopus 로고
    • High levels of circulating endothelial microparticles in patients with acute coronary syndromes
    • Bernal-Mizrachi L, Jy W, Jimenez J, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962–970.
    • (2003) Am Heart J , vol.145 , pp. 962-970
    • Bernal-Mizrachi, L.1    Jy, W.2    Jimenez, J.3
  • 49
    • 0033999142 scopus 로고    scopus 로고
    • Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
    • Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841–843.
    • (2000) Circulation , vol.101 , pp. 841-843
    • Mallat, Z.1    Benamer, H.2    Hugel, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.